PMGC Holdings Inc.
ELABHealthcare|Biotechnology|US
$1.61
-0.04 (-2.42%)
DCF Value
$847.13
Tangible Book / Share
$15.81
Cash / Share
$38.54
Financials
Financial Snapshot
Market Cap
$1.3M
Enterprise Value
-$2.9M
Revenue (TTM)
$2.6M
Net Income (TTM)
-$13.5M
Cash & Investments
$18.8M
Net Cash
$4.9M
Free Cash Flow (TTM)
-$9.0M
Operating CF (TTM)
-$8.2M
Debt/Equity
0.83
Cash Runway & Burn Rate
Cash on Hand
$18.8M
Quarterly Burn
$2.1M
Monthly Burn
$684.0K
Est. Runway
~9.2 quarters
| Metric | Trend | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Cash & Investments | $13.4K | $411.9K | $1.2M | $3.3M | $4.0M | $5.4M | $18.8M | |
| Operating Cash Flow | -$217.2K | -$660.9K | -$1.6M | -$4.6M | -$5.5M | -$5.9M | -$8.2M | |
| Free Cash Flow | -$217.2K | -$693.4K | -$1.6M | -$4.6M | -$5.5M | -$6.4M | -$9.0M | |
| Capital Expenditure | $0.00 | -$32.5K | -$35.5K | -$11.2K | -$9.2K | -$448.3K | -$777.8K | |
| Financing Cash Flow | $238.3K | $1.1M | $2.4M | $6.7M | $6.8M | $10.1M | $29.6M |
R&D Spending
R&D (TTM)
$405.2K
R&D Intensity
15.7%
R&D Growth vs Prior
+175.6%
| Metric | Trend | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $827.00 | $766.3K | $0.00 | $2.5M | $590.1K | $2.6M | |
| R&D Expense | $118.9K | $123.6K | $228.7K | $7.4K | $104.7K | $147.0K | $405.2K | |
| R&D % of Revenue | — | 14949.5% | 29.9% | — | 4.2% | 24.9% | 15.7% | |
| SG&A | $103.0K | $634.3K | $1.7M | $1.1M | $855.8K | $1.6M | $885.0K |
Income Statement
| Metric | Trend | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $827.00 | $766.3K | $0.00 | $2.5M | $590.1K | $2.6M | |
| Cost of Revenue | $0.00 | $88.00 | $319.0K | $554.00 | $670.2K | $515.3K | $2.3M | |
| Gross Profit | $0.00 | $739.00 | $447.3K | -$554.00 | $1.8M | $74.8K | $265.8K | |
| R&D | $118.9K | $123.6K | $228.7K | $7.4K | $104.7K | $147.0K | $405.2K | |
| SG&A | $103.0K | $634.3K | $1.7M | $1.1M | $855.8K | $1.6M | $885.0K | |
| Operating Income | -$221.8K | -$785.1K | -$1.8M | -$1.1M | -$1.9M | -$7.4M | -$12.3M | |
| Interest Expense | $0.00 | $0.00 | $2.6K | $0.00 | $735.2K | $547.1K | $2.2M | |
| Pretax Income | -$222.9K | -$784.7K | -$1.8M | -$1.7M | -$4.0M | -$7.7M | -$13.5M | |
| Net Income | -$222.9K | -$784.7K | -$1.8M | -$4.3M | -$6.2M | -$7.7M | -$13.5M | |
| EPS (Diluted) | -19.79 | -887.71 | -158.40 | -1511.43 | -65923.20 | -3787.40 | -1815.30 | |
| EBITDA | $0.00 | -$782.0K | -$1.8M | -$1.1M | -$3.3M | -$7.3M | -$12.0M | |
| Shares Out. (M) | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.49 |
Balance Sheet
| Metric | Trend | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $13.4K | $411.9K | $1.2M | $3.3M | $4.0M | $5.4M | $18.1M | |
| Short-Term Investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $650.6K | |
| Total Current Assets | $17.0K | $636.5K | $1.6M | $4.9M | $6.1M | $6.9M | $20.8M | |
| Total Assets | $17.0K | $666.3K | $1.9M | $5.2M | $9.0M | $12.9M | $36.6M | |
| Total Current Liabilities | $40.6K | $215.6K | $588.3K | $1.3M | $1.8M | $3.9M | $15.3M | |
| Long-Term Debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.1M | $4.2M | |
| Total Liabilities | $40.6K | $215.6K | $760.9K | $1.4M | $2.3M | $5.0M | $19.8M | |
| Stockholders' Equity | -$23.6K | $450.6K | $1.1M | $3.8M | $6.7M | $7.8M | $16.7M | |
| Retained Earnings | -$137.4K | -$922.1K | -$2.7M | -$7.0M | -$13.3M | -$21.0M | -$28.9M |
Cash Flow Statement
| Metric | Trend | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$217.2K | -$660.9K | -$1.6M | -$4.6M | -$5.5M | -$5.9M | -$8.2M | |
| Capital Expenditure | $0.00 | -$32.5K | -$35.5K | -$11.2K | -$9.2K | -$448.3K | -$777.8K | |
| Free Cash Flow | -$217.2K | -$693.4K | -$1.6M | -$4.6M | -$5.5M | -$6.4M | -$9.0M | |
| Investing Cash Flow | $0.00 | -$32.5K | -$32.0K | -$11.2K | -$610.6K | -$2.8M | -$8.9M | |
| Financing Cash Flow | $238.3K | $1.1M | $2.4M | $6.7M | $6.8M | $10.1M | $29.6M | |
| Issuance of Stock | $115.0K | $0.00 | $25.0K | $7.5M | $7.0M | $6.1M | $25.0M | |
| Repurchase of Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$179.00 | $0.00 | |
| Net Debt Issuance | $0.00 | $0.00 | $184.0K | $0.00 | -$235.6K | $0.00 | $51.9K | |
| Stock Based Comp. | $0.00 | $142.4K | $171.9K | $487.7K | $97.2K | -$19.2K | $174.5K | |
| Net Change in Cash | $19.6K | $398.5K | $743.0K | $2.2M | $657.6K | $1.4M | $12.5M |
Dilution Tracker
Shares Outstanding
1M
5-Year Share Growth
-81.9%
Stock Issuance (TTM)
$25.0M
| Metric | Trend | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Shares Out. (M) | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.49 | |
| Change vs Prior % | — | -92.2% | 1183.3% | -74.9% | -96.7% | 2042.1% | 23863.1% | |
| Stock Issuance | $115.0K | $0.00 | $25.0K | $7.5M | $7.0M | $6.1M | $25.0M | |
| Stock Repurchase | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$179.00 | $0.00 | |
| Stock Based Comp. | $0.00 | $142.4K | $171.9K | $487.7K | $97.2K | -$19.2K | $174.5K |
Margins & Profitability
| Metric | Trend | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Gross Margin % | — | 89.4% | 58.4% | — | 72.8% | 12.7% | 10.3% | |
| Operating Margin % | — | -94928.9% | -233.4% | — | -75.7% | -1250.1% | -477.0% | |
| Net Margin % | — | -94889.8% | -234.9% | — | -253.1% | -1306.3% | -523.0% | |
| EBITDA Margin % | — | -94556.5% | -233.7% | — | -132.5% | -1231.4% | -463.4% | |
| FCF Margin % | — | -83847.2% | -211.6% | — | -222.4% | -1081.6% | -348.4% | |
| ROE % | 945.0% | -174.1% | -159.1% | -112.4% | -93.8% | -98.4% | -118.1% | |
| ROA % | -1309.5% | -117.8% | -95.1% | -82.9% | -69.4% | -59.9% | -36.9% | |
| ROIC % | -53976.6% | -174.2% | -126.4% | -28.3% | -25.9% | -70.2% | -39.7% | |
| R&D / Revenue % | — | 14949.5% | 29.9% | — | 4.2% | 24.9% | 15.7% |
Growth (Year over Year)
Fiscal years. Rising share count growth means dilution.
| Metric | Trend | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 0.0% | 0.0% | 92557.4% | -100.0% | 0.0% | -76.1% | |
| Gross Profit | 0.0% | 0.0% | 60429.0% | -100.1% | 324486.5% | -95.8% | |
| Operating Income | 0.0% | -253.9% | -127.8% | 36.2% | -63.6% | -295.2% | |
| Net Income | 0.0% | -252.0% | -129.4% | -138.9% | -45.2% | -23.4% | |
| EPS (Diluted) | 0.0% | -4385.6% | 82.2% | -854.2% | -4261.6% | 94.3% | |
| Operating Cash Flow | 0.0% | -204.3% | -139.9% | -187.3% | -20.4% | -8.1% | |
| Free Cash Flow | 0.0% | -219.3% | -133.8% | -181.7% | -20.1% | -16.3% | |
| R&D Expense | 0.0% | 4.0% | 85.0% | -96.8% | 1312.3% | 40.5% | |
| SG&A Expense | 0.0% | 515.9% | 172.6% | -34.5% | -24.5% | 89.8% | |
| Total Assets | 0.0% | 3814.1% | 184.0% | 174.3% | 73.3% | 43.1% | |
| Book Value / Share | 0.0% | 24439.4% | -80.4% | 426292.1% | -83.5% | -94.5% | |
| Debt | 0.0% | -100.0% | 0.0% | -25.7% | -100.0% | 0.0% | |
| Diluted Shares | 0.0% | -92.2% | 1183.3% | -74.9% | -96.7% | 2042.1% |
Valuation
P/E (TTM)At Loss
P/S0.51
10Y Low / Med / High2.07 / 236769.99 / 17095940.02
P/B0.05
10Y Low / Med / High0.37 / 20.22 / 160372.84
EV/EBITDA0.24
EV/Revenue-1.13
10Y Low / Med / High0.23 / 236768.85 / 17095442.01
P/FCFAt Loss
Intrinsic Value Models (per share)
DCF Value
$847.13
Tangible Book / Share
$15.81
Net Current Assets / Share
$1.24
Cash / Share
$38.54
| Metric | Trend | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| P/E Ratio | -808165.74 | -18016.69 | -100969.70 | -17.99 | -0.82 | -0.38 | -0.00 | |
| P/S Ratio | 0.00 | 17095940.02 | 236769.99 | 0.00 | 2.07 | 4.90 | 0.51 | |
| P/B Ratio | -7636437.19 | 31374.75 | 160372.84 | 20.22 | 0.77 | 0.37 | 0.05 | |
| EV/EBITDA | 0.00 | -18079.61 | -101294.06 | -65.78 | -0.35 | -0.02 | 0.24 | |
| EV/Revenue | 0.00 | 17095442.01 | 236768.85 | 0.00 | 0.46 | 0.23 | -1.13 |
Analyst Estimates & Quality
Altman Z-Score
-1.95
Distress
Piotroski F-Score
3
Weak
Revenue Segments
By Geography
| Segment | 2023 |
|---|---|
| AUSTRIA | $234.8K |
| CANADA | $158.6K |
| UNITED STATES | $1.7M |
| VIET NAM | $70.7K |